Good clinical practice recommendations for the diagnosis and treatment of functional dyspepsia: An expert review from the Asociación Mexicana de Gastroenterología [0.03%]
墨西哥胃肠病学会关于功能性消化不良诊断和治疗的良好临床实践建议专家审查报告
R I Carmona-Sánchez,G Vázquez-Elizondo,M C Rodríguez-Leal et al.
R I Carmona-Sánchez et al.
Introduction and aims: Functional dyspepsia (FD) is a highly prevalent condition characterized by upper gastrointestinal symptoms with no apparent organic cause. It is a complex and multifactorial disease that frequently ...
Real-world experience with the diagnosis of bile acid malabsorption (BAM) using serum 7-alpha-C4 and 48-hour stool bile acids [0.03%]
血清7-α-C4和48小时粪便胆汁酸诊断胆汁酸吸收不良(BAM)的临床经验
G Mendoza-Domínguez,Z M Garrido-Santos,C Lau et al.
G Mendoza-Domínguez et al.
Introduction and aims: Bile acid malabsorption (BAM) is responsible for 30% of cases of diarrhea-predominant irritable bowel syndrome (IBS-D) or functional diarrhea and 63.5% of cases of diarrhea following cholecystectomy...
Clinical practice recommendations on the use of neuromodulators in gastroenterology: AMG (Asociación Mexicana de Gastroenterología) - AMNM (Asociación Mexicana de Neurogastroenterología y Motilidad) expert joint review [0.03%]
墨西哥胃肠病学和神经胃肠病学及运动功能协会联合专家审查的神经调质在胃肠病临床实践中的应用建议
O Gómez-Escudero,J M Remes-Troche,E Coss-Adame et al.
O Gómez-Escudero et al.
Disorders of gut-brain interaction (DGBI) are characterized by alterations in both central and peripheral gut-brain axis (GBA)-related stimuli, and include esophageal, gastroduodenal, intestinal and anorectal disorders. Despite the fact tha...
Eosinophilic esophagitis: Current concepts of pathophysiology, diagnosis, and treatment [0.03%]
嗜酸性食管炎：病理生理、诊断和治疗的新概念
D García-Compeán,A R Jiménez-Rodríguez,C E González-Martínez
D García-Compeán
Eosinophilic esophagitis (EoE) is a chronic, immune-mediated disease characterized by the infiltration of eosinophils into the esophageal mucosa. It is the most frequent cause of dysphagia and food impaction in adults. Due to its similar pa...
Pharmacologic treatment of irritable bowel syndrome. Position statement of the Asociación Mexicana de Gastroenterología, 2024 [0.03%]
2024年墨西哥胃肠病学会关于肠易激综合征药物治疗的立场声明
J M Remes-Troche,E Coss-Adame,M Schmulson et al.
J M Remes-Troche et al.
Introduction: The aim of this position statement is to provide health professionals with an updated and evidence-based guideline for the pharmacologic management of irritable bowel syndrome (IBS) in Mexico. ...
Good clinical practice recommendations for proton pump inhibitor prescription and deprescription. A review by experts from the AMG [0.03%]
合理使用质子泵抑制剂的临床实践建议-AME专家评述
L R Valdovinos-García,A S Villar-Chávez,F M Huerta-Iga et al.
L R Valdovinos-García et al.
Introduction and aim: Proton pump inhibitors (PPIs) are widely known drugs that are used quite frequently and indicated in both the short and long terms, in numerous acid-related diseases. Our aim was to produce an expert...
Transitioning from NAFLD to MAFLD to MASLD in the Mexican population [0.03%]
墨西哥人群从NAFLD过渡到MAFLD再到MASLD的研究
B A Priego-Parra,R Bernal-Reyes,M E Icaza-Chávez et al.
B A Priego-Parra et al.
Clinical description of adults with eosinophilic esophagitis treated at a Chilean university center [0.03%]
智利大学成人嗜酸细胞性食管炎患者的临床特征
C von Muhlenbrock,P Núñez,R Quera et al.
C von Muhlenbrock et al.
Introduction and aim: Eosinophilic esophagitis (EoE) is a chronic immune-mediated inflammatory disease that affects the esophagus. Its epidemiology in Chile and Latin America is unknown due to the absence of population st...
An App model that utilizes a logistic regression algorithm for predicting choledocholithiasis: A prospective clinical trial [0.03%]
一种利用逻辑回归算法预测胆总管结石的APP模型：一项前瞻性临床试验
F García-Villarreal,L M Torres-Treviño,C Herrera-Figueroa et al.
F García-Villarreal et al.
Introduction and aim: The diagnostic yield of the current criteria for assigning the risk of choledocholithiasis (CL) is inaccurate. The aim of our work was to develop a logistic regression model for predicting CL diagnos...
Periprocedural and perioperative anticoagulation management strategies in liver cirrhosis [0.03%]
肝硬化的围手术期抗凝管理策略
M Porres-Aguilar,R Izaguirre-Ávila,M Uribe
M Porres-Aguilar